Shareholders' Equity (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of significant assumptions determining the fair value of the warrant liability |
The fair value of the Debt Modification Warrants upon issuance was determined using the Black-Scholes option pricing model with the following assumptions:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of warrants that remain outstanding |
The following table summarizes the warrants that remain outstanding as of March 31, 2025:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of restricted stock units (RSUs) outstanding |
A summary of the status of the RSUs outstanding is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of share options outstanding |
A summary of the status of the share options outstanding is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of share options that remain outstanding |
The following table summarizes the share options that remain outstanding as of March 31, 2025:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- Definition Tabular disclosure of the outstanding warrants. No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of share options that remain outstanding. No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|